Private Equity
London-based Babylon Health, a health service provider that provides remote consultations with doctors and health care professionals, has secured $550 million in funding. The investors included PIF, Munich Re, Kinnevik AB and Vostok New Ventures.
1 min read · 02 August 2019
Linden Capital Partners has acquired Oakland, New Jersey-based Collagen Matrix Inc, a maker of collagen-based medical products used for tissue and bone repair and regeneration across orthopedic, sports medicine, dental, and neurosurgery end markets. No financial terms were disclosed. William Blair was financial adviser to Linden on the deal while Robert W. Baird and Piper Jaffray did likewise for CMI.
2 min read · 01 August 2019
How Bain leverages collaboration with tech, life sciences teams
2 min read · 01 August 2019
San Francisco-based Prellis Biologics, a human tissue engineering company, has raised $8.7 million in Series A funding. Khosla Ventures led the round.
1 min read · 01 August 2019
Level Equity has made an investment in Planet DDS, the company behind Denticon, a dental practice management software solution provider. No financial terms were disclosed.
3 min read · 01 August 2019
Acuity Eyecare Group, a portfolio company of Riata Capital Group, has acquired 11 regional eyecare practices in Texas. No financial terms were disclosed.
3 min read · 01 August 2019
Cambridge, Massachusetts and Baltimore-based Thrive Earlier Detection Corp, a healthcare company focused on incorporating earlier cancer detection into routine medical care, has named David J. Daly as CEO. Previously, Daly worked at Illumina, where he was the senior vice president and general manager of commercial operations for the Americas region. Thrive Earlier Detection Corp's backers include Section 32, Casdin Capital, Biomatics Capital, BlueCross BlueShield Venture Partners, The Invus Group and Exact Sciences.
3 min read · 01 August 2019
Devin O’Reilly is a managing director at Bain Capital, where as a member of the North American Private Equity team he helps lead the firm’s healthcare investing efforts.
5 min read · 01 August 2019
Wellington Partners has raised 210 million euros for fifth fund. Wellington Partners Life Science Fund V's limited partners include KfW Capital, Talanx, UTIMCO, the University of Texas/Texas A&M Investment Company and European Investment Fund. Wellington Partners invests in early and growth-stage life science companies.
4 min read · 31 July 2019
EQT has agreed to acquire a majority stake in Fargo, North Dakota-based Aldevron, a producer of nucleic acids, proteins, and antibodies. No financial terms were disclosed. TA Associates will retain a minority stake in Aldevron. Morgan Stanley served as financial adviser to EQT on the deal while Goldman Sachs did likewise for TA Associates.
5 min read · 31 July 2019
